.jpg)
.png)
Top Stories
The NLA and Foundation of the NLA Recognize Renowned Physician and Researcher Dr. Joseph L. Witztum With Highest Honor, W. Virgil Brown Distinguished Achievement Award Speakers from around the world will be presenting their latest research and science at the upcoming National Lipid Association (... more
Esperion has announced that NEXLETOL™ (bempedoic acid) is now available in pharmacies in the United States. NEXLETOL is an oral, once-daily, tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH... more
Familial Hypercholesterolemia (FH) is among the most common genetic lipid disorders; left untreated, FH patients have a 20-fold increased risk for CHD. Primary Issues Website - July 24, 2011
Esperion has announced that NEXLIZET™ (bempedoic acid and ezetimibe) Is now available in pharmacies in the United States. NEXLIZET™ is an oral, once-daily, fixed-dose combination tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous... more
For heart health, you're supposed to know your numbers: total cholesterol, the bad LDL kind and the good HDL kind. Associated Press - November 7, 2011
On Friday, May 3, the U.S. FDA approved LIPTRUZET (ezetimibe and atorvastatin) tablets for the treatment of elevated low-density lipoprotein (LDL) cholesterol in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough. For more information, please... more
The window for nominations to NLA and Chapter leadership positions is now open through February 28, 2021. Open positions include: National Lipid Association positions include: At-Large Board Member (up to 7) Chapter positions include: President-Elect Treasurer... more
All U.S. children between the ages of 9 and 11 should be screened for high cholesterol, according to new guidelines endorsed by the nation's leading group of pediatricians. U.S. News & World Report - November 11, 2011
The National Lipid Association (NLA) has named Matthew Ito, PharmD (’86), as its new president. Membership of the NLA includes physicians, pharmacists, researchers, nurses, physician assistants and dietitians. USC School of Pharmacy News – June 2013
The U.S. Food and Drug Administration released a Drug Safety Communication on July 20, 2021, concerning the removal of the strongest warning against using statins during pregnancy. The warning states that statins should never be used in any patients during pregnancy. After reviewing recent... more